Buprenorphine depot - Acorda Therapeutics
Alternative Names: BuprelLatest Information Update: 13 Jan 2022
At a glance
- Originator DrugAbuse Sciences
- Developer Biotie Therapies Corp.
- Class Cyclopropanes; Drug withdrawal therapies; Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Opioid-related disorders
Most Recent Events
- 20 Jul 2010 Discontinued - Preclinical for Opioid abuse in European Union (IM)
- 19 Jan 2007 elbion NV acquires buprenorphine depot from DrugAbuse Sciences
- 31 Oct 2006 This compound is still in active development